Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice

Arthritis Research and Therapy

Volumn 8, Issue 5, 2006, Pages

  Sakurai, Yoshihiko ^a,b   Brand, David D ^c   Tang, Bo ^a   Rosloniec, Edward F ^c   Stuart, John M ^c   Kang, Andrew H ^a,c   Myers, Linda K ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b NATIONAL HOSPITAL ORGANIZATION   (Japan)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; EPITOPE; GAMMA INTERFERON; HLA DR ANTIGEN; HLA DR4 ANTIGEN; HLA DRB1 ANTIGEN; HLA-DRB1*04:01 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 4; PROTEIN BINDING;

AMINO ACID SUBSTITUTION; ANIMAL; ARTHRITIS, EXPERIMENTAL; BOVINAE; CELL CULTURE; DROSOPHILA; DRUG EFFECTS; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; T LYMPHOCYTE; TRANSGENIC MOUSE;

AMINO ACID SUBSTITUTION; ANIMALS; ARTHRITIS, EXPERIMENTAL; CATTLE; CELLS, CULTURED; COLLAGEN TYPE II; DROSOPHILA; EPITOPES; HLA-DR ANTIGENS; HLA-DR4 ANTIGEN; HLA-DRB1 CHAINS; IMMUNODOMINANT EPITOPES; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-4; MICE; MICE, TRANSGENIC; PROTEIN BINDING; T-LYMPHOCYTES;

EID: 39049140507     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2043     Document Type: Article

References (26)

1. Nepom GT, Byers P, Seyfried C, Healey LA, Wilske KR, Stage D, Nepom BS: HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotide probes. Arthritis Rheum 1989, 32:15-21.
2. Stastny P, Ball E, Kahn M, Olsen N, Pincus T, Gao X: HLA-DR4 and other genetic markers in rheumatoid arthritis. Br J Rheumatol 1988, 27:132-138.
3. Wordsworth BP, Lanchbury JS, Sakkas LI, Welsh KI, Panayi GS, Bell JI: HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc Natl Acad Sci USA 1989, 86:10049-10053.
4. Kim WU, Yoo WH, Park W, Kang YM, Kim SI, Park JH, Lee SS, Joo YS, Min JK, Hong YS, et al.: IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis. J Rheumatol 2000, 27:575-581.
5. Londei M, Savill CM, Verhoef A, Brennan F, Leech ZA, Duance V, Maini RN, Feldmann M: Persistence of collagen type II-specific T cell clones in synovial membrane of a patient with rheumatoid arthritis. Proc Natl Acad Sci USA 1989, 86:636-640.
6. Jasin HE: Autoantibody specificities of immune complexes sequestered in articular cartilage of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1985, 28:241-248.
7. Watson WC, Cremer MA, Wooley PH, Townes AS: Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis. Arthritis Rheum 1986, 29 1316-1321.
8. Watson WC, Tooms RE, Carnesale PG, Dutkowski JP: A case of germinal center formation by CD45RO T and CD20 B lymphocytes in rheumatoid arthritis subchondral bone: Proposal for a two compartment model of immune-mediated disease with implications for immunotherapeutic strategies. Clin Immunol Immunopathol 1994, 73:27-37.
9. Rosloniec EF, Brand DD, Myers LK, Whittington KB, Gumanovskaya M, Zaller DM, Woods A, Altmann DM, Stuart JM, Kang AH: An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J Exp Med 1997, 185:1113-1122.
10. Rosloniec EF, Brand DD, Myers LK, Esaki Y, Whittington KB, Zaller DM, Woods A, Stuart JM, Kang AH: Induction of autoimmune arthritis in HLA-DR4 (DRB1·0401) transgenic mice by immunization with human and bovine type II collagen. J Immunol 1998, 160:2573-2578.
11. Rosloniec EF, Whittington KB, Zaller DM, Kang AH: HLA-DR1 (DRB1·0101) and DR4 (DRB1·0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen J Immunol 2002, 168:253-259.
12. Myers LK, Sakurai Y, Tang B, He X, Rosloniec EF, Stuart JM, Kang AH: Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice. Arthritis Rheum 2002, 46:3369-3377.
13. Woods A, Chen HY, Trumbauer ME, Sirotina A, Cummings R, Zaller DM: Human major histocompatibility complex class II restricted T cell responses in transgenic mice. J Exp Med 1994, 180:173-181.
14. Rosloniec EF, Kang AH, Myers LK, Cremer MA: Collageninduced arthritis In Current Protocols in Immunology Edited by: Coico R, Shevach E. New York: Wiley & Sons; 1997:15.15.11-15.15.24.
15. Hill CM, Liu A, Marshall KW, Mayer J, Jorgensen B, Yuan B, Cubbon RM, Nichols EA, Wicker LS, Rothbard JB: Exploration of requirements for peptide binding to HLA DRB1·0101 and DRB1·0401. J Immunol 1994, 152:2890-2898.
16. Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegard D, van den Berg WB: Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Arthritis Res 1999, 1:81-91.
17. Kim SH, Kim S, Evans CH, Ghivizzani SC, Oligino T, Robbins PD: Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4. J Immunol 2001, 166:3499-3505.
18. Watanabe S, Imagawa T, Boivin GP, Gao G, Wilson JM, Hirsch R: Adeno-associated virus mediates long-term gene transfer and delivery of chondroprotective IL-4 to murine synovium. Mol Ther 2000, 2 147-152.
19. Tanaka Y, Otsuka T, Hotokebuchi T, Miyahara H, Nakashima H, Kuga S, Nemoto Y, Niiro H, Niho Y: Effect of IL-10 on collageninduced arthritis in mice. Inflamm Res 1996, 45:283-288.
20. Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC: Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994, 368 215-221.
21. Sette A, Buus S, Colon S, Smith JA, Miles C, Grey HM: Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells. Nature 1987, 328:395-399.
22. Sette A, Buus S, Appella E, Smith JA, Chesnut R, Miles C, Colon SM, Grey HM: Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. Proc Natl Acad Sci USA 1989, 86:3296-3300.
23. Scott CA, Peterson PA, Teyton L, Wilson IA: Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues. Immunity 1998, 8:319-329.
24. Dessen A, Lawrence CM, Cupo S, Zaller DM, Wiley DC: X-ray crystal structure of HLA-DR4 (DRA·0101 DRB1·0401) complexed with a peptide from human collagen II. Immunity 1997, 7:473-481.
25. Nepom GT: Tetramer analysis of human autoreactive CD4- positive T cells. Adv Immunol 2005, 88:51-71.
26. + T cells. Blood 2005, 106:2798-2805.